Category: Q&A

Vision, Cutting-Edge Technology, and Deep Expertise. Interview with the Scientists at Propath UK, the Royals Among the CROs.

A few years ago, the UK Prime Minister's office announced that Propath, a trusted specialist in molecular pathology for biopharmaceutical research and development, had been nominated to receive a Queen's Award for Enterprise in recognition of the company's exceptional contribution...

/ November 2, 2020

ROSALIND® by OnRamp Bio: A new platform for nCounter® expression analysis.

Recently NanoString® has announced its partnership with OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, to integrate our knowledge and expertise into an optimized analysis experience for nCounter with the ROSALIND® Analysis Platform. ROSALIND, named after pioneering scientist Rosalind...

/ October 19, 2020

Serotonin, Gut-Brain-Microbiome Axis and an Inspired Young Scientist. How a Core Facility is Born. Q&A with Prof. Beate Niesler, Institute of Human Genetics, University of Heidelberg, Germany.

Imagine you are setting up for an interview with a prominent professor at the University of Heidelberg in Germany, in which you will focus on how a scientific interest triggered the need for new technology, and how acquiring that technology...

/ September 14, 2020

Molecular Signatures of Antibody-Mediated Rejection and Graft Outcome After Kidney Transplantation. Q&A with Dr. Dela Golshayan, M.D., Ph.D.

When Newsweek Magazine rates you the 9th best Hospital in the World, you know you are doing something remarkable!  Located in Lausanne, Switzerland, Lausanne University Hospital (CHUV) sits on Lake Geneva and is surrounded by snowcapped and picturesque Swiss mountain peaks....

/ August 31, 2020

All Things Grants. Q&A with a Grant Reviewer and two Grant Writers – Tips & Tricks for Success.

"An advice I would give to a beginner grant writer is to take the reviewer by hand, take him one step at the time in a logical fashion through that grant proposal." Dr. Thompson Grant writing is an integral part...

/ August 17, 2020